Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy

Optometry

Volumn 78, Issue 2, 2007, Pages 63-70

  Diller, Rebecca ^a   Thompson, Kelly ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Highly antiretroviral therapy; Immune reconstitution disease; JC virus; Progressive multifocal leukoencephalopathy

Indexed keywords

ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG DERIVATIVE; EFAVIRENZ; LAMIVUDINE; OXAZINE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR;

AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; DRUG COMBINATION; HEMIANOPIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; ISOLATION AND PURIFICATION; JC VIRUS; LEUKOENCEPHALOPATHY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; VIROLOGY; VISUAL DISORDER; VISUAL FIELD;

ADENINE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CEREBROSPINAL FLUID; DRUG THERAPY, COMBINATION; HEMIANOPSIA; HUMANS; JC VIRUS; LAMIVUDINE; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXAZINES; PHOSPHONIC ACIDS; TOMOGRAPHY, X-RAY COMPUTED; VISION DISORDERS; VISUAL FIELDS;

EID: 33846380601     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2006.10.014     Document Type: Article

References (53)

1. Astrom K.E., Mancall E.L., and Richardson Jr. E.P. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 81 1 (1958) 93-111
2. Padgett B.L., Walker D.L., ZuRhein G.M., et al. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1 7712 (1971) 1257-1260
3. Bofill-Mas S., and Girones R. Role of the environment in the transmission of JC virus. J Neurovirol 9 (2003) 54-58 (suppl)1
4. Brown P., Tsai T., and Gajdusek D.C. Seroepidemiology of human papovavirus. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 102 4 (1975) 331-340
5. Walker D.L., and Padgett B.L. The epidemiology of human polyomaviruses. Prog Clin Biol Res 105 (1983) 99-106
6. Bergui M., Bradac G.B., Oguz K.K., et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 46 1 (2004) 22-25
7. Ouwens J.P., Haaxma-Reiche H., Verschuuren E.A., et al. Visual symptoms after lung transplantation: a case of progressive multifocal leukoencephalopathy. Transpl Infect Dis 2 1 (2000) 29-32
8. Gasnault J., Kahraman M., de Goer de Herve M.G., et al. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. Aids 17 10 (2003) 1443-1449
9. Berger J.R. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 9 suppl 1 (2003) 38-41
10. Houff S.A., Major E.O., Katz D.A., et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318 5 (1988) 301-305
11. Antinori A., Cingolani A., Lorenzini P., et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 9 suppl 1 (2003) 47-53
12. Berger J.R., Pall L., Lanska D., et al. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4 1 (1998) 59-68
13. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 RR-17 (1992) 1-19
14. Holman R.C., Janssen R.S., Buehler J.W., et al. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 41 11 (1991) 1733-1736
15. Sacktor N., Lyles R.H., Skolasky R., et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56 2 (2001) 257-260
16. Karahalios D., Breit R., Dal Canto M.C., et al. Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr 5 10 (1992) 1030-1038
17. von Einsiedel R.W., Fife T.D., Aksamit A.J., et al. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 240 7 (1993) 391-406
18. Kastrup O., Maschke M., Diener H.C., et al. Progressive multifocal leukoencephalopathy limited to the brain stem. Neuroradiology 44 3 (2002) 227-229
19. Ormerod L.D., Rhodes R.H., Gross S.A., et al. Ophthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leukoencephalopathy. Ophthalmology 103 6 (1996) 899-906
20. Slavin M.L., Mallin J.E., and Jacob H.S. Isolated homonymous hemianopsia in the acquired immunodeficiency syndrome. Am J Ophthalmol 108 2 (1989) 198-200
21. von Giesen H.J., Neuen-Jacob E., Dorries K., et al. Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci 147 1 (1997) 63-72
22. Appen R.E., Roth H., ZuRhein G.M., et al. Progressive multifocal leukoencephalopathy. A cause of visual loss. Arch Ophthalmol 95 4 (1977) 656-659
23. Zuger A. Visual complaints in an HIV-infected man. AIDS Clin Care 7 5 (1995) 41-44
24. Du Pasquier R.A., and Koralnik I.J. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?. J Neurovirol 9 suppl 1 (2003) 25-31
25. Chaisson R.E., and Griffin D.E. Progressive multifocal leukoencephalopathy in AIDS. JAMA 264 1 (1990) 79-82
26. Kotecha N., George M.J., Smith T.W., et al. Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status?. Am J Med 105 6 (1998) 541-543
27. Berger J.R., and Mucke L. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 38 7 (1988) 1060-1065
28. Thurnher M.M., Thurnher S.A., Muhlbauer B., et al. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 39 9 (1997) 611-618
29. Hammarin A.L., Bogdanovic G., Svedhem V., et al. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy. J Clin Microbiol 34 12 (1996) 2929-2932
30. Fong I.W., Britton C.B., Luinstra K.E., et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33 2 (1995) 484-486
31. Post M.J., Yiannoutsos C., Simpson D., et al., AIDS Clinical Trials Group, 243 Team. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival?. AJNR Am J Neuroradiol 20 10 (1999) 1896-1906
32. Berger J.R., Levy R.M., Flomenhoft D., et al. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44 3 (1998) 341-349
33. Miralles P., Berenguer J., Lacruz C., et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15 14 (2001) 1900-1902
34. Enting R.H., and Portegies P. Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy. J Neurol 247 2 (2000) 134-138
35. De Luca A., Giancola M.L., Ammassari A., et al. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 182 4 (2000) 1077-1083
36. Cinque P., Pierotti C., Vigano M.G., et al. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J Neurovirol 7 4 (2001) 358-363
37. Berger J.R. Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2 4 (2000) 361-368
38. Miralles P., Berenguer J., Garcia de Viedma D., et al. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12 18 (1998) 2467-2472
39. Giudici B., Vaz B., Bossolasco S., et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30 1 (2000) 95-99
40. Emery S., and Lane H.C. Immune reconstitution in HIV infection. Curr Opin Immunol 9 4 (1997) 568-572
41. Royal III W., Dupont B., McGuire D., et al. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 9 3 (2003) 411-419
42. Steiger M.J., Tarnesby G., Gabe S., et al. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33 4 (1993) 407-411
43. Razonable R.R., Aksamit A.J., Wright A.J., et al. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 76 11 (2001) 1171-1175
44. French M.A., Lenzo N., John M., et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 1 2 (2000) 107-115
45. Jacobson M. Clinical implications of immune reconstruction in AIDS. HIV InSite (2006)
46. Price P., Mathiot N., Krueger R., et al. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 22 3 (2001) 279-287
47. Safdar A., Rubocki R.J., Horvath J.A., et al. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 35 10 (2002) 1250-1257
48. Stoll M., and Schmidt R.E. Adverse events of desirable gain in immunocompetence: the immune restoration inflammatory syndromes. Autoimmun Rev 3 4 (2004) 243-249
49. Shelburne III S.A., and Hamill R.J. The immune reconstitution inflammatory syndrome. AIDS Rev 5 2 (2003) 67-79
50. Shelburne S.A., Visnegarwala F., Darcourt J., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19 4 (2005) 399-406
51. Friis-Moller N., Sabin C.A., Weber R., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 21 (2003) 1993-2003
52. d'Arminio A., Sabin C.A., Phillips A.N., et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 18 13 (2004) 1811-1817
53. Garcia de Viedma D., Alonso R., Miralles P., et al. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J Clin Microbiol 37 3 (1999) 724-728